Aarti Industries is a leading Indian manufacturer of Speciality Chemicals and Pharmaceuticals with a global footprint. Chemicals manufactured by Aarti are used in the downstream manufacture of pharmaceuticals, agrochemicals, polymers, additives, surfactants, pigments, dyes, etc.
Edelweiss, as the left lead banker to the deal, hand-held the management with end-to-end execution, structuring the deal, swift regulatory approvals, and timely launch. The QIP received an overwhelming response from all categories of investors and the deal was launched in 4 weeks from kick off.
Edelweiss Financial Services Spearheaded demand mobilization: book was oversubscribed multiple times and saw participation from a diverse investor set.